Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SKE | BILL |
|---|---|---|
| Price | $30.24 | $44.49 |
| Change today | ▲ 1.00% | ▲ 1.99% |
| Market cap | $3.79B | $3.79B |
| Return, 3 months | +12.2% | +9.4% |
| Return, year to date | +27.4% | -18.4% |
| Return, 1 year | +66.7% | -16.6% |
| P/E (TTM) | -20.8 | -404.5 |
| P/B | 31.7 | 1.1 |
| P/E percentile vs own 5y | – | 12th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +13.0% |
| Net profit growth (YoY) | – | -147.2% |
| Gross margin | – | 80.9% |
| Operating margin | – | 1.1% |
| Net margin | – | -0.7% |
| Return on equity | – | -0.3% |
| Analyst target vs. price | +43.8% | +31.3% |
| Analyst buy share | 100% | 62% |
| RSI (14) | 45 | 45 |
| 30-day volatility | 50.6% | 39.1% |
| Max drawdown, 1 year | -34.7% | -43.2% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
